Healthcare -
Biotechnology - NASDAQ - US
$ 1.89
-0.526 %
$ 141 M
Market Cap
-1.63
P/E
IKT - INTEREST INCOME & EXPENSE
Interest Income & Expense IKT - Inhibikase Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR